Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma

NCT02068586 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University as lead sponsor.

NCT NCT02068586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02068586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 19, 2014
Completion date
December 31, 2026
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ciliary body and choroid melanoma, medium/large size, ciliary body and choroid melanoma, small size, iris melanoma, stage i intraocular melanoma, stage i uveal melanoma ajcc v7, stage ii uveal melanoma ajcc v7, stage iia intraocular melanoma, stage iib intraocular melanoma, stage iii uveal melanoma ajcc v7, stage iiia intraocular melanoma, stage iiib intraocular melanoma, stage iiic intraocular melanoma